What Fueled The Previous Growth In The Antipyretic Drugs For Children Market?
The antipyretic drugs for children market has seen considerable growth due to a variety of factors.
• There has been a substantial growth in the market size for antipyretic drugs for children in past few years. The market is expected to rise from $3.21 billion in 2024 to $3.43 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.0%.
Factors contributing to this growth during the historic period include an increased awareness about children's health leading to more demand for antipyretic drugs, a higher occurrence of fever-related diseases in children globally, an upsurge in healthcare expenditure by families to address common fevers in children, enhanced availability of over-the-counter antipyretic drugs in emerging markets, and amplified focus on preventative healthcare and early intervention in pediatric fevers.
How Does the Forecast Look for the Antipyretic Drugs For Children Market Size?
The antipyretic drugs for children market is expected to maintain its strong growth trajectory in upcoming years.
• The market for antipyretic medications for children is projected to experience substantial growth in the upcoming years, with an expected value of $4.43 billion in 2029 and a compound annual growth rate (CAGR) of 6.6%.
This growth in the forecast period is likely influenced by several factors such as increased emphasis on advancements in pediatric healthcare, which further amplifies the demand for safer antipyretic drugs, heightened cases of viral infections among children necessitating antipyretic treatments, government efforts to enhance accessibility to pediatric healthcare in developing nations, advancements in drug formulations and delivery methods that improve the effectiveness of antipyretics, and the expansion of pharmaceutical firms in emerging markets, thereby increasing the availability of pediatric medications. Key trends to be anticipated during the forecast period encompass technological advancements in pediatric drug formulations for quicker and safer relief from fever, a shift towards natural and herbal antipyretic medications for children, emphasis on personalized pediatric treatments for fever management, increased use of telemedicine platforms for pediatric consultations concerning fever management, and the creation of combination antipyretic drugs that address multiple symptoms in children.
What Factors Are Driving Growth In The Antipyretic Drugs For Children Market?
The surge in viral and bacterial infection rates is predicted to drive the expansion of the children's antipyretic drug market. Viral infections, caused by invading and replicating viruses inside host cells, lead to diseases such as the flu. Bacterial infections are the result of harmful bacteria infiltrating the body and multiplying, causing conditions like strep throat or tuberculosis. The increased incidence of these infections can be attributed to factors like antibiotic resistance, widespread travel, and high population density, which encourage the dissemination of pathogens. Antipyretic medications like acetaminophen or ibuprofen are used in children to lower fever and ease discomfort from these infections. For instance, The Office for National Statistics, a UK-based non-ministerial department, reported in May 2022 that from December 2021 to March 2022, there were 6,898 deaths due to flu and pneumonia in the UK. This is up from the 5,288 deaths in the same timeframe in 2020-2021, signaling an increase of more than 1,600 year-over-year deaths. Hence, the escalating numbers of viral and bacterial infections are propelling the growth of the children's antipyretic drug market.
How Are The Segments Defined Within The Global Antipyretic Drugs For Children Market?
The antipyretic drugs for childrenmarket covered in this report is segmented –
1) By Drug Class: Acetaminophen, Ibuprofen, Other Drug Classes
2) By Dosage Form: Tablets, Syrups, Suppositories, Other Dosage Forms
3) By Age Group: Newborns, Infants, Toddlers, Children
Subsegments:
1) By Acetaminophen: Oral Suspension, Chewable Tablets, Suppositories
2) By Ibuprofen: Oral Suspension, Chewable Tablets, Suppositories
3) By Other Drug Classes: Aspirin, Naproxen
Pre-Book The Antipyretic Drugs For Children Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Antipyretic Drugs For Children Market?
Leading organizations in the antipyretic drugs for children market are concentrating on the invention of progressive drug formulations, including medicine gummy bites, to simplify administration and boost adherence among juvenile patients. The attraction of these chewable, gummy-style medications is their ability to make medicine dosage more palatable, specifically for children. They come in an array of shapes and flavors which enhances children's willingness to take them, thus streamlining the process. Take for example DrKids, a pharmaceutical firm based in the US, which took the initiative to release an acetaminophen gummy bite in October 2023. This revolutionary medicine provides an appealing alternative for children's pain and fever relief. It includes an accurate dosage system that makes medication distribution easier for parents, while also safeguarding its efficiency and safety.
Who Are the Key Players In The Antipyretic Drugs For Children Market?
Major companies operating in the antipyretic drugs for children market are:
• Pfizer Inc.
• Johnson & Johnson
• Merck & Co. Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A.
• Bristol Myers Squibb
• GlaxoSmithKline plc
• Reckitt Benckiser Group
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company plc
• Aurobindo Pharma Ltd.
• Dr. Reddy’s Laboratories Ltd.
• Cipla Ltd.
• Lupin Limited
• Towa Pharmaceutical Co Ltd.
• Glenmark Pharmaceuticals Ltd.
• Alkem Laboratories Limited
What Is The Most Dominant Region In The Antipyretic Drugs For Children Market?
North America was the largest region in the antipyretic drugs for children market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipyretic drugs for children market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
